Misinfo Radar

FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness

Attention level: Low (18 sources)

• Headline mismatch 4 of 19 confidence: low Articles whose headline says something its own description does not.
  • Quartz: FDA is requiring weight loss drug makers to add a vision loss warning
    The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION
  • The Seattle Times: FDA adds rare vision-loss warning to popular GLP-1 drugs
    The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic.
  • ABC News (US): FDA adds rare vision-loss warning to popular GLP-1 drugs
    The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic

Every outlet on this story